Imbruvica Archives -

AbbVie, J&J embed Imbruvica deeper in CLL therapy with new approval

https://pharmaphorum.com/news/abbvie-jj-embed-imbruvica-deeper-in-cll-therapy-with-new-approval/

BeiGene’s Brukinsa fails to beat AbbVie/J&J’s Ibrutinib in WM

https://pharmaphorum.com/news/beigenes-brukinsa-fails-to-beat-abbvie-jjs-ibrutinib-in-wm/

ASH19: AZ’s Calquence throws gauntlet down to Imbruvica

https://pharmaphorum.com/news/ash19-azs-calquence-throws-gauntlet-down-to-imbruvica/

FDA nod for AZ’s Calquence sets up new Imbruvica showdown

https://pharmaphorum.com/news/fda-nod-for-azs-calquence-sets-up-new-imbruvica-showdown/

AbbVie and J&J claim new Imbruvica okay in US

https://pharmaphorum.com/news/abbvie-and-jj-claim-new-imbruvica-okay-in-us/

AbbVie and J&J’s Imbruvica fails pancreatic cancer test

https://pharmaphorum.com/news/abbvie-and-jjs-imbruvica-fails-pancreatic-cancer-test/

China’s BeiGene delays US filing for rival to Imbruvica

https://pharmaphorum.com/news/chinas-beigene-delays-us-filing-for-rival-to-imbruvica/

Janssen’s Imbruvica latest to gain NICE approval after price cut

https://pharmaphorum.com/news/janssens-imbruvica-latest-gain-nice-approval-price-cut/

Decision to axe Afinitor ‘confirms worst fears’ for Cancer Drug Fund

https://pharmaphorum.com/news/decision-axe-afinitor-confirms-worst-fears-cancer-drug-decisions/

Search